首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1672137

全球藥物發現資訊學市場研究報告-產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Drug Discovery Informatics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球藥物發現資訊學市場規模預計將從 2024 年的 36.4743 億美元成長到 2033 年的 79.8427 億美元，在 2026 年至 2033 年的預測期內呈現 9.1% 的強勁年複合成長率(CAGR)。

藥物研發資訊學市場正在經歷顯著的成長，這得益於藥物開發過程日益複雜以及對高效資料管理解決方案的需求。藥物發現資訊學涵蓋一系列工具和技術，有助於在整個藥物開發生命週期中分析、視覺化和管理生物和化學資料。隨著製藥公司尋求加快其研發力度，對增強協作和資料整合的資訊解決方案的需求預計將上升，從而使該市場實現強勁擴張。

此外，資訊科技的進步正在推動藥物發現資訊學市場的創新。人工智慧 (AI)、機器學習 (ML) 和巨量資料分析的融合正在改變研究人員分析大量資料集的方式，從而能夠更有效地識別潛在的候選藥物。這些技術促進了預測模型、虛擬篩選和資料探勘，大大減少了與藥物發現相關的時間和成本。隨著研究不斷探索藥物發現資訊學的新方法和新應用，在藥物開發效率提高和創新的推動下，市場可能會進一步擴大。

此外，研究機構和製藥公司之間越來越重視合作和資料共享，這正在塑造藥物發現資訊學格局。隨著利害關係人認知到協作研究努力的價值，對支援跨平台資料整合和共享的資訊解決方案的需求可能會增加。這一趨勢在開放科學計劃的背景下尤其重要，因為資料的透明度和可近性對於推進藥物研發工作至關重要。隨著藥物發現資訊學市場不斷發展，技術進步、協作研究模式和對數據驅動決策的關注將在塑造其未來發展方面發揮關鍵作用。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 9 章：藥物發現資訊學公司的競爭格局

藥物發現資訊學市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Certara

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Infosys Ltd.

公司概況
公司收入
產品
最新動態

Charles River Laboratories

公司概況
公司收入
產品
最新動態

Collaborative Drug Discovery Inc.

公司概況
公司收入
產品
最新動態

Eurofins DiscoverX Products

公司概況
公司收入
產品
最新動態

Jubliant Biosys

公司概況
公司收入
產品
最新動態

Selvita

公司概況
公司收入
產品
最新動態

Novo Informatics Pvt. Ltd.

公司概況
公司收入
產品
最新動態

ChemAxon Ltd.

公司概況
公司收入
產品
最新動態

Albany Molecular Research Inc.

公司概況
公司收入
產品
最新動態

Oracle

公司概況
公司收入
產品
最新動態

Accenture

公司概況
公司收入
產品
最新動態

Agilent Technologies Inc.

公司概況
公司收入
產品
最新動態

Illumina Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR112115285

Global Drug Discovery Informatics Market size is anticipated to grow from USD 3647.43 Million in 2024 to USD 7984.27 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period of 2026 to 2033.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

Drug Discovery
Drug Development

By Function

Sequencing and Target Data Analysis
Library and Database Preparation
Docking
Molecular Modelling
Others

By End User

Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Other End Users
COMPANIES PROFILED
Certara Inc.
Accenture
Thermo Fisher Scientific Inc.
Jubilant Pharmova
Oracle Corporation
Albany Molecular Research Inc.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DRUG DISCOVERY INFORMATICS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Function
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Drug Discovery Historic and Forecast Sales By Regions
5.4. Drug Development Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY FUNCTION

6.1. Overview By Function
6.2. Historical and Forecast Data Analysis By Function
6.3. Sequencing and Target Data Analysis Historic and Forecast Sales By Regions
6.4. Library and Database Preparation Historic and Forecast Sales By Regions
6.5. Docking, Molecular Modelling Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Biotechnology Companies Historic and Forecast Sales By Regions
7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
7.5. Contract Research Organizations Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY INFORMATICS COMPANIES

9.1. Drug Discovery Informatics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF DRUG DISCOVERY INFORMATICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Certara
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Boehringer Ingelheim International GmbH
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Infosys Ltd.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Charles River Laboratories
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Collaborative Drug Discovery Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Eurofins DiscoverX Products
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Jubliant Biosys
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Selvita
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novo Informatics Pvt. Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. ChemAxon Ltd.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Albany Molecular Research Inc.
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Oracle
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Accenture
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Agilent Technologies Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Illumina Inc
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Application (USD MN)
Drug Discovery Market Sales By Geography (USD MN)
Drug Development Market Sales By Geography (USD MN)
Analysis By Function (USD MN)
Sequencing and Target Data Analysis Market Sales By Geography (USD MN)
Library and Database Preparation Market Sales By Geography (USD MN)
Docking, Molecular Modelling Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By End User (USD MN)
Biotechnology Companies Market Sales By Geography (USD MN)
Pharmaceutical Companies Market Sales By Geography (USD MN)
Contract Research Organizations Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Drug Discovery Informatics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Drug Discovery Informatics Report
Market Research Process
Market Research Methodology
Global Drug Discovery Informatics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By Function
Market Attractiveness Analysis By End User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Application (USD MN)
Drug Discovery Market Sales By Geography (USD MN)
Drug Development Market Sales By Geography (USD MN)
Global Market Analysis By Function (USD MN)
Sequencing and Target Data Analysis Market Sales By Geography (USD MN)
Library and Database Preparation Market Sales By Geography (USD MN)
Docking, Molecular Modelling Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By End User (USD MN)
Biotechnology Companies Market Sales By Geography (USD MN)
Pharmaceutical Companies Market Sales By Geography (USD MN)
Contract Research Organizations Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.